|
|
|
Insider
Information: |
Bb Biotech Ag |
Relationship: |
|
City: |
Schaffhausen |
State: |
V8 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
34,381,515 |
|
Indirect Shares
|
2,001,074 |
|
|
Direct
Value |
$244,826,621 |
|
|
Indirect Value
|
$9,064,865 |
|
|
Total
Shares |
36,382,589 |
|
|
Total
Value |
$253,891,487 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
80
|
0
|
Stock
price went up :
|
22
|
0
|
Stock
price went down : |
58
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-14.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Monogram Biosciences Inc |
134495-OLD |
10% Owner |
2003-12-29 |
2,001,074 |
2003-12-29 |
2,001,074 |
Premium* |
|
Radius Health Inc. |
RDUS |
10% Owner |
2022-08-11 |
0 |
2014-06-06 |
0 |
Premium* |
|
Cidara Therapeutics, Inc. |
CDTX |
10% Owner |
2017-11-15 |
2,295,272 |
2017-11-15 |
0 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
2021-05-24 |
4,477,964 |
2018-05-18 |
0 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
|
2024-04-02 |
1,279,820 |
|
0 |
Premium* |
|
Macrogenics Inc |
MGNX |
10% Owner |
2023-10-02 |
9,929,963 |
|
0 |
Premium* |
|
ESSA Pharma Inc |
EPIX |
10% Owner |
2022-07-18 |
5,879,583 |
|
0 |
Premium* |
|
Black Diamond Therapeutics, Inc. |
BDTX |
|
2023-10-17 |
8,517,839 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
134495-OLD |
Monogram Biosciences Inc |
10% Owner |
|
2003-12-29 |
4 |
OE |
$1.21 |
$2,421,300 |
I/I |
2,001,074 |
2,001,074 |
|
- |
|
134495-OLD |
Monogram Biosciences Inc |
10% Owner |
|
2003-12-29 |
4 |
OE |
$1.21 |
$2,421,300 |
D/D |
2,001,074 |
2,001,074 |
|
- |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-04-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,735,846 |
|
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-04-12 |
4 |
B |
$3.42 |
$513,600 |
D/D |
150,000 |
3,885,846 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-04-13 |
4 |
B |
$3.57 |
$366,217 |
D/D |
102,556 |
3,988,402 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-04-18 |
4 |
B |
$3.29 |
$493,935 |
D/D |
150,000 |
4,138,402 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-04-19 |
4 |
B |
$3.24 |
$486,645 |
D/D |
150,000 |
4,288,402 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-04-27 |
4 |
B |
$2.66 |
$399,480 |
D/D |
150,000 |
4,438,402 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-04-28 |
4 |
B |
$2.57 |
$657,868 |
D/D |
255,711 |
4,694,113 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-10-19 |
4 |
B |
$1.32 |
$102,775 |
D/D |
77,689 |
4,771,802 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-10-20 |
4 |
B |
$1.42 |
$76,345 |
D/D |
53,734 |
4,825,536 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-10-21 |
4 |
B |
$1.51 |
$132,750 |
D/D |
87,850 |
4,913,386 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-10-27 |
4 |
B |
$1.87 |
$359,224 |
D/D |
191,678 |
5,105,064 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-10-28 |
4 |
B |
$2.18 |
$376,962 |
D/D |
172,974 |
5,278,038 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2022-10-31 |
4 |
B |
$2.25 |
$224,912 |
D/D |
99,801 |
5,377,839 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
10% Owner |
|
2023-06-27 |
4 |
B |
$5.49 |
$9,555,036 |
D/D |
1,740,000 |
7,117,839 |
2.45 |
% |
|
BDTX |
Black Diamond Therapeutic... |
|
|
2023-06-30 |
4 |
B |
$5.00 |
$5,000,000 |
D/D |
1,000,000 |
8,117,839 |
0.01 |
% |
|
BDTX |
Black Diamond Therapeutic... |
|
|
2023-10-17 |
4 |
B |
$2.34 |
$934,080 |
D/D |
400,000 |
8,517,839 |
0.01 |
% |
|
CDTX |
Cidara Therapeutics, Inc. |
10% Owner |
|
2017-11-15 |
4 |
B |
$7.57 |
$453,966 |
D/D |
60,000 |
2,295,272 |
2.45 |
- |
|
EPIX |
ESSA Pharma Inc |
10% Owner |
|
2021-08-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,765,814 |
|
- |
|
EPIX |
ESSA Pharma Inc |
10% Owner |
|
2021-08-18 |
4 |
B |
$8.88 |
$2,218,800 |
D/D |
250,000 |
5,015,814 |
2.45 |
- |
|
EPIX |
ESSA Pharma Inc |
10% Owner |
|
2022-04-27 |
4 |
S |
$5.85 |
$146,925 |
D/D |
(25,100) |
4,990,714 |
0 |
- |
|
EPIX |
ESSA Pharma Inc |
10% Owner |
|
2022-07-14 |
4 |
B |
$2.79 |
$969,428 |
D/D |
347,204 |
5,337,918 |
2.45 |
- |
|
EPIX |
ESSA Pharma Inc |
10% Owner |
|
2022-07-15 |
4 |
B |
$3.13 |
$756,798 |
D/D |
241,665 |
5,579,583 |
2.45 |
- |
|
EPIX |
ESSA Pharma Inc |
10% Owner |
|
2022-07-18 |
4 |
B |
$3.16 |
$946,740 |
D/D |
300,000 |
5,879,583 |
2.45 |
- |
|
169 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|